Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
BioLargo, Inc
BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 – 4:00 PM Eastern Time
September 9, 2026
BioLargo’s Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution
September 3, 2026
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
September 1, 2026
BioLargo to Participate in Gabelli Funds’ 4th Annual PFAS Symposium in New York
August 25, 2026
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
August 17, 2026
BioLargo’s Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons
August 3, 2026
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors
July 30, 2026
BioLargo Equipment Solutions & Technologies’ “PFAS Lady” to Teach PFAS 101 at 41st Annual Tri-State Seminar
July 29, 2026
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
July 27, 2026
BioLargo Relaunching CupriDyne(R)-Based Consumer Products – Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
July 13, 2026
1
2
Next Page
→